Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Embecta Corp.

EMBCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$10.57
$-0.16(-1.49%)
U.S. Market opens in 17h 21m

Embecta Corp. Fundamental Analysis

Embecta Corp. (EMBC) shows moderate financial fundamentals with a PE ratio of 4.47, profit margin of 12.92%, and ROE of -20.90%. The company generates $1.1B in annual revenue with weak year-over-year growth of -3.80%.

Key Strengths

Operating Margin32.06%
Cash Position33.16%
PEG Ratio0.10
Current Ratio2.64

Areas of Concern

ROE-20.90%
We analyze EMBC's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 43.4/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
43.4/100

We analyze EMBC's fundamental strength across five key dimensions:

Efficiency Score

Excellent

EMBC demonstrates superior asset utilization.

ROA > 10%
13.11%

Valuation Score

Excellent

EMBC trades at attractive valuation levels.

PE < 25
4.47
PEG Ratio < 2
0.10

Growth Score

Moderate

EMBC shows steady but slowing expansion.

Revenue Growth > 5%
-3.80%
EPS Growth > 10%
20.59%

Financial Health Score

Excellent

EMBC maintains a strong and stable balance sheet.

Debt/Equity < 1
-2.32
Current Ratio > 1
2.64

Profitability Score

Weak

EMBC struggles to sustain strong margins.

ROE > 15%
-2090.28%
Net Margin ≥ 15%
12.92%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is EMBC Expensive or Cheap?

P/E Ratio

EMBC trades at 4.47 times earnings. This suggests potential undervaluation.

4.47

PEG Ratio

When adjusting for growth, EMBC's PEG of 0.10 indicates potential undervaluation.

0.10

Price to Book

The market values Embecta Corp. at -1.02 times its book value. This may indicate undervaluation.

-1.02

EV/EBITDA

Enterprise value stands at -1.65 times EBITDA. This is generally considered low.

-1.65

How Well Does EMBC Make Money?

Net Profit Margin

For every $100 in sales, Embecta Corp. keeps $12.92 as profit after all expenses.

12.92%

Operating Margin

Core operations generate 32.06 in profit for every $100 in revenue, before interest and taxes.

32.06%

ROE

Management delivers $-20.90 in profit for every $100 of shareholder equity.

-20.90%

ROA

Embecta Corp. generates $13.11 in profit for every $100 in assets, demonstrating efficient asset deployment.

13.11%

Following the Money - Real Cash Generation

Operating Cash Flow

Embecta Corp. produces operating cash flow of $217.55M, showing steady but balanced cash generation.

$217.55M

Free Cash Flow

Embecta Corp. generates strong free cash flow of $209.01M, providing ample flexibility for dividends, buybacks, or growth.

$209.01M

FCF Per Share

Each share generates $3.53 in free cash annually.

$3.53

FCF Yield

EMBC converts 32.58% of its market value into free cash.

32.58%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

4.47

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.10

vs 25 benchmark

P/B Ratio

Price to book value ratio

-1.02

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.59

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-2.32

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.64

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.21

vs 25 benchmark

ROA

Return on assets percentage

0.13

vs 25 benchmark

ROCE

Return on capital employed

0.42

vs 25 benchmark

How EMBC Stacks Against Its Sector Peers

MetricEMBC ValueSector AveragePerformance
P/E Ratio4.4729.43 Better (Cheaper)
ROE-20.90%800.00% Weak
Net Margin12.92%-20145.00% (disorted) Strong
Debt/Equity-2.320.30 Strong (Low Leverage)
Current Ratio2.644.64 Strong Liquidity
ROA13.11%-17936.00% (disorted) Strong

EMBC outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Embecta Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-2.70%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-78.19%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-62.41%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ